The results were sobering. Heartwire from Medscape, July 11, 2014 Nonalcoholic Fatty Liver Disease Guidelines Released by WGO Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ...

DWP figures sourced by charity Benefits and Work looking at working-age claimants, show which claimants with which health ...

People with one of five conditions are the most likely to receive up to £749.80 a month in payments from the Department for ...

Dr Ray O’Connor takes a look at the latest clinical articles on gastrointestinal cancers – which comprise more than ...

I maintain a Buy rating on Zymeworks Inc. stock due to platform promise and upcoming catalysts. However, click for why I am ...

FGFR1-targeting Pemazyre was approved by the FDA for previously treated biliary tract tumours with FGFR2 gene fusions in 2020, becoming the first targeted therapy for the disease, and last year ...

A recent study from Japan likewise failed to identify reovirus RNA in frozen biliary atresia hepatobiliary ... patients at diagnosis and 0 of 12 liver disease control patients showed evidence ...

Lynch syndrome is a hereditary condition that sharply raises the risk of several types of cancer. Caused by inherited ...

Over the last 7 days, the United States market has risen by 1.2%, and over the past year, it has climbed by 11%, with earnings forecasted to grow annually by 14%. In this context of growth, ...

University of Alberta researchers have created a new tool to help doctors and patients recognize other illnesses commonly ...

AstraZeneca’s (AZ) Imfinzi (durvalumab) has been approved in the European Union (EU) as first-line treatment of adult patients with unresectable or metastatic biliary tract cancer (BTC ...

Myelodysplastic syndromes (MDS) are a group of disorders that typically arise in adulthood, especially after the age of 70, ...